Standardisation of breast radiotherapy (START) trial

Institute of Cancer Research (UK)0 个研究点目标入组 4,451 人开始时间: 2000年4月6日最近更新: 2022年11月7日

适应症

试验速览

2008 Results article in http://www.ncbi.nlm.nih.gov/pubmed/18355913 March results on 'Trial A' 2008 Results article in http://www.ncbi.nlm.nih.gov/pubmed/18356109 April results on 'Trial B' 2010 Results article in http://www.ncbi.nlm.nih.gov/pubmed/20138809 results

•1. Patients must be 18 years and above, have operable unilateral breast cancer (T1-3, NO-1, MO at presentation)
•2. There must be histological confirmation of invasive carcinoma and complete macroscopic excision of tumour by breast conserving surgery or mastectomy
•3. The patient must consent to be part of the study and be available for follow-up

•Patients requiring axillary radiotherapy after greater than a level 1 axillary dissection or after greater than 10 lymph nodes have been removed

发起方

Institute of Cancer Research (UK)